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ABSTRACT 
Amavata is a Kapkavatavyadhi affecting people in the Madhyamaavasta. 
The disease is obtained by the involvement of Ama and Vata, 
characterized by Ruja and Shotha in Sandhisthanas. In this study the aims 
and objectives are to evaluate the effect of Nittyavirechana in Amavata, 
To evaluate the additive efficacy of Yogabasti in Amavata and To evaluate 
the comparative effect of Nittyavirechana and Yogabasti in Amavata. 
This was a prospective comparative clinical trial. Patients were randomly 
distributed into 2 groups which are 15 patients receiving Nittyavirechana 
with Erandataila and another 15 patients received Yogabasti with 
Erandamooladikwathaniruha and Bruhatsandhavaditailaanuvasana 
Results in group A 6.66% patients had good, 73.33% patients had 
moderate and 20% patients had mild response to the treatment. In group 
B 40% patients had good response, 60% patients had moderate response 
to the treatment. There was considerable improvement subjective and 
objective parameters in both the groups but Yogabasti group got more 
beneficial effects. 
Nittyavirechana imparts Agnideepana, Vatanulomana and opens up the 
Srotas in the Shareera facilitating more nourishment and free movement 
of Vatadosha. Yogabasti is prime treatment for Amavata in turn plays 
vital role in correcting pathology of the disease and gives remarkable 
results. 
 
INTRODUCTION 
Amavata was first described as an 
independent disease in Madhava Nidana. Amavata 
is characterized by Angamarda (body ache), Aruchi 
(tastelessness), Trishna (thirst), Alasya (lack of 
enthusiasm), Gouravam (heaviness all over body), 
Jwara (Fever), Apaka (indigestion) and Shunata 
Anganam (swelling all over the body mainly in 
joints).[1] It is a disease of Madhyama Roga Marga as 
it affects Sandhis and Hridaya Marma. Though Ama 
and Vata are the predominant pathogenic factors 
but the disease represents Tridoshic vitiation. The 
affliction of Sandhis by Vatadosha in association 
with Ama, reflects the equal role of both Dosha and 
Dushya in the causation of this disease. Moreover, 
the chief pathogenic factors, being contradictory in 
nature possess difficulty in planning the line of 
treatment.  
Rheumatoid arthritis (RA) is a chronic 
systemic autoimmune inflammatory disease that 
affects mainly the small joints of the hands and feet. 
RA is one of the most common inflammatory joint 
diseases and causes premature mortality, disability 
and compromised quality of life. Burden of RA is 
widely prevalent throughout the world. The 
worldwide prevalence is 0.8% and steadily 
increases to 5% in women over the age of 70. 
Rheumatoid arthritis is two to three times more 
common in women than in men. In India the 
prevalence is to be 0.7%.[2] This condition can be 
correlated to rheumatoid arthritis which is 
characterized by Joint pain, tenderness, swelling or 
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stiffness for six weeks or longer, Morning stiffness 
for 30 minutes or longer, more than one joint is 
affected, small joints (wrists, certain joints of the 
hands and feet) are affected, the symmetrical joints 
of the body are affected, along with pain, many 
people experience of fatigue, loss of appetite and 
low-grade fever.[3] 
AIMS AND OBJECTIVES 
1. To study the effect of Nittyavirechana with 
Erandataila in Amavata.  
2. To evaluate the efficacy of Yogabasti with 
Erandamooladikwathaniruha and Bruhat-
sandhavaditailaanuvasana in Amavata. 
3. To compare the efficacy of above two procedure 
in Amavata. 
Materials and Methods 
A total of 30 patients having the features of 
Amavata were selected for the study irrespective of 
sex, occupation, religion and socio-economic status 
from Shalakyatantra OPD & IPD of DGM. Ayurveda 
Medical College and Hospital, Gadag. 
The materials taken for the study are 
Vaishwanara churna,  Erandataila, Bruhatsaindha-
vaditaila, Erandamooladi Niruhabasti, and Placebo 
Capsules.  
The diagnosis was made on the basis of 
classical signs and symptoms mentioned in the 
Ayurveda and modern texts and criteria laid down 
by American Rheumatism Association (1988).[4] 
Following features are employed for 
confirmation of RA. 
1) Morning stiffness (> = 1hr)  
2) Swelling of three or more joints  
3) Swelling of hand joints (PIP, MP)  
4) Symmetrical swelling  
5) Subcutaneous nodules (Rheumatoid nodules) 
6) Presence of serum rheumatoid factor 
7) Radiological changes (Hands & wrist) 
Criteria 1 to 4 must have been continuous for 6 
weeks or longer must be observed by physician. A 
diagnosis of RA requires that, four of the above 
seven criteria should be present.  
a) Inclusion criteria 
1. Classical signs and symptoms will be 
considered for the selection of patients. 
2. Patients of Amavata having the history of less 
than 5 years. 
3. Patients of Amavata between the age group of 
20 to 60 years of either sex. 
4. Patient fit for Virechana and Basti karma. 
 
b) Exclusion criteria 
1. Patients of Amavata having the history of more 
than 5 years. 
2. The patient of Amavata having the systemic 
diseases like Diabetes mellitus, Asthma, 
Hypertension, Rheumatic heart disease and 
Heart diseases etc. 
3. Pregnant or lactating women. 
Objective parameters 
The below investigations are done before the 
selection of patient for the study. 
1. Hb%, 2. ESR, 3. ASL O titer, 4. CRP, 5. Rh factor, 
Subjective parameters 
The subjective parameters taken for this study are  
1. Ruja,  2. Shotha, 3. Stabdata,  4. Ushnata 
Study Design  
The patients were administered 
Vaishwanara choorna internally in a dose of 3 – 
6gms thrice daily with a cup of hot water, half an 
hour before food. The treatment was given till the 
Nirama laxanas were observed. For patients of 
Group A: Erandataila in the quantity of 15 to 30ml 
was given in between 8 to 9am when the patient is 
not so hungry for 8 days for the purpose of 
Nittyavirechana, according to the Kosta of the 
patient. A cup of hot water was advised as Anupana. 
Group B: Yogabasti was given with Bruhat-
saindhavaditaila Anuvasanabasti and Eranda-
mooladi Niruhabasti. For both groups Pariharakala 
was advised for 16 days. In Pariharakala one 
Placebo capsules were advised to take daily for 
benefits of good follow up. Valukasweda was 
advised whenever patient complaints increased 
pain and stiffness during the course of the 
treatment for both groups. 
Grading 
 The lab test values were recorded before and 
after treatment. 
 The subjective parameter were graded from 
Grade-0 to Grade-4 based on presence of null, 
one, two, three or four of the following 
symptoms in a particular Sandhi: Ruja, Shotha, 
Stabdhata and Ushnata. 
Overall Assessment of the Treatment 
 To assess the overall effect of therapy, the 
criteria laid down by ARA (1967) were adopted. 
The results are classified into four groups as listed 
below. 
Grade I - Complete Remission 
1=No systemic sign of rheumatoid activity 
2=No signs of inflammation 
Suresh N. Hakkandi, Shashidhar.H. Doddamani. A Comparative Study of Virechana Karma and Basti Karma in Amavata  
AYUSHDHARA | September - October 2018 | Vol 5 | Issue 5  1859 
3=No evidence of activity in any extra articular 
process, including nodules tendovaginitis and iritis. 
4=No lasting impairment of joint mobility other 
than that associated with irreversible changes 
5=No elevation in ESR 
6=Articular deformity or extra articular 
involvement due to irreversible changes may be 
present. 
Grade II - Major Improvement 
1=No systemic sign of rheumatoid activity with the 
exception of an elevated sedimentation rate and 
vasomotor imbalance. 
2=Major signs of inflammation resolved, such as 
warmth, redness of joint structures. 
3=No new rheumatoid process of intra articular or 
extra articular structures. 
4=Minimum joint swelling may be present. 
5=Impairment of joint mobility associated with 
minimum residual activity may be present. 
6=Articular deformity or extra-articular 
involvement due to irreversible changes may be 
present. 
Grade III - Minor Improvement 
1=Diminution of systemic signs of Rheumatoid 
activity. 
2=Signs of joint inflammation only partially 
resolved 
3=No evidence of extension of rheumatoid activity 
into additional articular or extra articular 
structures. 
4=Decreased but not minimum joint swelling 
present. 
5=Impairment of joint mobility may be present. 
6=Articular deformity or extra articular 
involvement due to reversible changes may be 
present. 
Grade IV – Unimprovement or Progression 
1=Undiminished signs of rheumatoid activity, 
regardless of functional activity. 
2=Exacerbation of any previously involved joint or 
joints or development of sites of rheumatoid 
activity. 
3=Roentgenologic changes indicative of progression 
of the rheumatoid process, excepting hypertrophic 
changes. 
4=In the presence of 1 or more of the before said 
criteria, improvement in other feature, including a 
normal or lowered ESR, not significant. 
Composition of Test Drug 
 Vaishvanara churna:[5] Manimantha, Yavani, 
Ajamoda, Nagara and Haritaki. 
 Brihatsaindhava taila:[6] Saindhava, Sreyasi, 
Shatapuopa, Rasna, Vavanika, Sarija, Maricha, 
Kusta, Shunti, Suvacchala, Vida, Vacha, Ajamoda, 
Madhuka, Jeeraka, Puskaramula and Kana. 
 Erandamooladi Vasti:[7] Erandamoola, Palasha, 
Rasna, Bala, Guduchi Ashwaganda, Punarnava, 
Aragvadha, Devadaru, Madanaphala, Shalaparni, 
Prasnaparni, Gokshura, Kantakari, Bruhati, 
Vacha, Hapusha, Shatavha, Priyangu, Yasti-
madhu, Kana, Vatsakabeeja, Musta, Taksharya-
shaila, Saindhavalavana, Makshika, Taila and 
Gomootra. 
RESULTS 
Table 1: Showing statistical analysis of subjective and objective parameters in group A 
S.No Parameters Mean SD SE T value P value 
1 Hasta 1.8 0.774 0.2 9.00 < 0.001 
2 Pada 1.533 0.743 0.191 8.026 < 0.001 
3 Gulpha 1.466 0.743 0.191 7.67 < 0.001 
4 Trika 1.133 0.516 0.133 8.518 < 0.001 
5 Janu 1.133 0.617 0.159 2.183 < 0.001 
6 Uru 0.666 0.487 0.125 5.328 < 0.001 
7 Siro 0.4 0.057 0.130 3.076 < 0.001 
8 Hb% 0.22 0.086 0.022 10.00 < 0.001 
9 ESR 25.8 17.78 4.59 5.620 < 0.001 
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Table 2: Showing statistical analysis of subjective and objective parameters in group B 
S.No Parameters Mean SD SE T value P value 
1 Hasta 1.733 0.798 0.206 8.412 < 0.001 
2 Pada 1.533 0.743 0.191 8.026 < 0.001 
3 Gulpha 1.6 0.506 0.131 12.213 < 0.001 
4 Trika 1.00 0.377 0.097 10.309 < 0.001 
5 Janu 1.666 0.487 0.125 13.328 < 0.001  
6 Uru 0.8 0.5606 0.144 5.55 < 0.001 
7 Siro 0.333 0.487 0.125 2.666 < 0.001  
8 Hb% 0.313 0.172 0.044 7.11 < 0.001 
9 ESR 27.466 14.38 3.714 7.39 < 0.001 
Table 3: Showing the comparative statistical analysis of subjective and objective parameters in both 
groups 
Parameters  Mean SD SE PSE T value P value Remarks 
Hasta A 0.666 0.723 0.186 0.301  1.551 > 0.05 NS 
B 1.133 0.915 0.236 
Pada A 0.6 0.632 0.163 0.243 2.74 < 0.02 HS 
B 1.266 0.703 0.181 
Gulpha A 0.866 0.351 0.090 0.161 4.14 < 0.001 HS 
B 1.533 0.516 0.133 
Trika A 0.466 0.516 0.133 0.196 1.704 > 0.05 NS 
B 0.8 0.560 0.144 
Janu A 0.733 0.703 0.181 0.263 1.520 > 0.05 NS 
B 1.133 0.743 0.191 
Uru A 0.0666 0.258 0.066 0.148 2.698 < 0.02 NS 
B 0.4660 0.516 0.133 
Siro A 0.0666 0.258 0.066 0.112 0.598 > 0.05 NS 
B 0.133 0.351 0.090 
Hb% A 10.14 1.012 0.263 0.397 0.74 > 0.05 NS 
B 9.846 1.156 0.298 
ESR A 28.066 8.647 2.232 4.65 0.287 > 0.05 NS 
B 26.73 15.8 4.080 
At the end of treatment there are significant 
changes in Shoola, Shotha, Stabdata and Ushnata in 
Yogabasti group compared to Nittyavirechana 
group showing the P value < 0.001. This signifies 
that Yogabasti possibly had a greater role in the 
management of Amavata. 
DISCUSSION 
The disease Rheumatoid arthritis is 
identical with the signs and symptoms of Amavata. 
It always challenges to the physicians due to its 
chronicity, complication and morbidity, this disease 
mainly affects the musculo skeletal system. It has 
also extra articular manifestations affecting cardio-
vascular, nervous and excretory systems, which is 
collectively known as connective tissue or collagen 
disorder. Line of treatment, Nittyavirechana and 
Yogabasti, which is explained in Ayurveda, can 
reduce pain, swelling, and protection of joints and 
control the disease progression. 
Ricinoelic acid of Erandataila irritates bowel 
leading to Virechana as it is having Ushnavirya, it 
also does Pachana karma (Amapachana). It 
alleviates Doshavriddi by expelling out, and dose 
Srotoshodhana. Bruhat Saindhavadi Taila used for 
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Anuvasanabasti as a Poorvakarma for Niruhabasti 
so that it prepares the Kosta by its Snigdhagunas to 
receive Niruhabasti. The ingredients of this Taila 
possess Deepana, Pachana, Vatanulomana, 
Shothahara properties. The ingredients of Eranda-
mooladiniruhabasti mainly possess Deepana, 
Pachana, Ushna, Sukshma, Laghu, Ruksha, Snigdha, 
Teekshna and Lekhanagunas. These Gunas helps to 
alleviate Ama and Vata in the body. 
CONCLUSION 
By results and observations it becomes 
evident that effect of Yogabasti was more beneficial 
in Shoola, Shotha, Stabdata and Usnata of different 
Sandhis, when compared to that of Nittyavirechana 
group. But as the disease is Yapya or autoimmune 
nature the completely permanent remission cannot 
be expected. 
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